Walleye Trading
FOLD

Walleye Trading’s Amicus Therapeutics FOLD Stock Holding History

Walleye Trading’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.69M Sell
116,600
-166,200
-59% -$2.38M ﹤0.01% 1817
2025
Q4 		$4.03M Buy
282,800
+272,300
+2,593% +$2.68M 0.01% 1420
2025
Q3 		$82.7K Buy
10,500
+4,300
+69% +$30.6K ﹤0.01% 3799
2025
Q2 		$35.5K Buy
+6,200
New +$40K ﹤0.01% 3887
2024
Q1 		– Sell
-8,700
Closed -$123K – 4962
2023
Q4 		$123K Sell
8,700
-122,000
-93% -$1.39M ﹤0.01% 4047
2023
Q3 		$1.59M Buy
+130,700
New +$1.69M ﹤0.01% 1964
2023
Q1 		– Sell
-9,600
Closed -$117K – 5008
2022
Q4 		$117K Sell
9,600
-6,100
-39% -$68.7K ﹤0.01% 3893
2022
Q3 		$164K Buy
15,700
+14,900
+1,863% +$166K ﹤0.01% 3827
2022
Q2 		$9K Sell
800
-20,700
-96% -$170K ﹤0.01% 4656
2022
Q1 		$204K Buy
21,500
+16,800
+357% +$158K ﹤0.01% 3770
2021
Q4 		$54K Sell
4,700
-42,200
-90% -$470K ﹤0.01% 4646
2021
Q3 		$448K Sell
46,900
-22,500
-32% -$230K ﹤0.01% 3022
2021
Q2 		$669K Sell
69,400
-82,200
-54% -$802K ﹤0.01% 2569
2021
Q1 		$1.5M Buy
151,600
+136,400
+897% +$2.11M 0.01% 1582
2020
Q4 		$351K Buy
15,200
+14,500
+2,071% +$297K ﹤0.01% 2993
2020
Q3 		$10K Buy
+700
New +$10.2K ﹤0.01% 3912
2020
Q2 		– Sell
-2,300
Closed -$21K – 4351
2020
Q1 		$21K Sell
2,300
-3,800
-62% -$36.1K ﹤0.01% 3620
2019
Q4 		$59K Buy
+6,100
New +$55.8K ﹤0.01% 3756
2019
Q2 		– Sell
-7,300
Closed -$99K – 4197
2019
Q1 		$99K Sell
7,300
-48,200
-87% -$589K ﹤0.01% 3462
2018
Q4 		$532K Buy
55,500
+33,100
+148% +$364K ﹤0.01% 2420
2018
Q3 		$271K Buy
22,400
+12,400
+124% +$173K ﹤0.01% 3492
2018
Q2 		$156K Buy
+10,000
New +$151K ﹤0.01% 3798

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Walleye Trading's FOLD Position: Q1 2026 in Review

Walleye Trading reduced its Amicus Therapeutics (FOLD) stake by 88% in Q1 2026, selling an estimated $2.65M and leaving 25,604 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #2762.

Walleye Trading first reported a position in FOLD in Q1 2019 and has held it in 10 quarters since. The position peaked at $3M in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Walleye Trading held 25,604 shares of Amicus Therapeutics worth $370K as of Q1 2026.
  • Walleye Trading sold 184,974 Amicus Therapeutics shares in Q1 2026, an estimated $2.65M.
  • Amicus Therapeutics made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #2762 holding.
  • Walleye Trading first reported a position in Amicus Therapeutics in Q1 2019 and has held it in 10 quarters since.
  • Walleye Trading's Amicus Therapeutics position peaked at $3M in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.